WindRose Health Investors LLC, a New York City-based healthcare private equity firm, has completed an equity recapitalization of Veristat Group Inc. Veristat is a scientifically minded global clinical research organization that seeks to assist biotech and pharmaceutical sponsors to advance complex therapeutic challenges and accelerate innovative therapies. The company provides services along the entire clinical therapeutic development spectrum through regulatory approval and post-approval, including strategic consulting, regulatory affairs, clinical operations, biostatistics, data management, medical writing, and pharmacovigilance.
Patrick Flanagan, Veristat chief executive officer, commented, “Veristat’s focus is to build true partnerships with our clients as we help them overcome intricate challenges in developing ground-breaking products that improve and save lives through our differentiated approach to designing and executing clinical trials, clinical programs, regulatory submissions, and pharmacovigilance. We are thrilled to partner with WindRose as we continue to execute our growth strategy. In addition to capital, WindRose’s deep network of relationships and expertise in the biotech and pharmaceutical markets will be incredibly valuable as we strategically grow our Company.”
“We are excited to be partnering with Veristat’s highly experienced team,” said CJ Burnes, partner with WindRose. “We are impressed with the company’s clinical impact and scientific approach to partnering with companies advancing life-enhancing therapies. Their market position, stellar reputation, and leadership within biostatistics and complex clinical trials is unlike any other we have seen, and Veristat’s client population is growing rapidly. WindRose has meaningful experience in partnering with companies serving rapidly expanding markets, and we plan to contribute substantial resources to support Veristat’s continued expansion in partnership with the management team and founders.”
Edgemont Partners acted as financial advisor to Veristat. McDermott Will & Emery LLP acted as legal advisor to WindRose, and Nutter McClennen & Fish LLP acted as legal advisor to Veristat.